Abstract In kidney nephron, parietal epithelial cells line the Bowman's capsule and function as a permeability barrier for the glomerular filtrate. Bowman's capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman's capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman's capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman's capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman's capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman's capsule but did not colocalize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman's capsule. This study identified the localization of SGLT2 in the Bowman's capsule. Bowman's capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.
Introduction
Nutrients and electrolytes that are filtered through the glomerulus of the kidney are reabsorbed mainly in the proximal tubule region of nephron (Nielsen et al. 2012) . Parietal epithelial cells line the glomerular capsule (Bowman's capsule) and function as a permeability barrier for the glomerular filtrate. At the glomerulotubular junction, the Bowman's capsule cell layer abruptly ends and the proximal tubule epithelium begins. This transition can be easily distinguished by light microscopy as parietal epithelial cells appear flat and lack brush border membrane (BBM), while proximal tubule epithelial cells are tall and cuboidal and have well-developed BBM (Nielsen et al. 2012 ). Bowman's capsules with proximal tubule-like cell layer were first observed several decades ago in kidneys of mice (Crabtree 1940) and later on were found in the human kidney (Rosenheim 1953) . Tubular metaplasia in Bowman's capsule has been seen in kidneys of patients with diabetes, lupus (Finckh and Joske 1954) , acute glomerular nephritis (Hutt et al. 1958) , and acute tubular necrosis (Solez et al. 1979 ). More recently, scanning electron microscopic examination of nephrectomy samples showed tubularized Bowman's capsules in up to 18 % of nephrons (Lindop et al. 2002) . The cellular structures of human, mouse, and rat tubularized Bowman's capsules are well studied and shown to be indistinguishable from that of the proximal tubule cells (Ahmadizadeh et al. 1984; Finckh and Joske 1954; Lee et al. 1993; Jakowski 1982; Ward 1970) . However, so far, little is known about the cause of tubular metaplasia in Bowman's capsule or its effects on kidney function.
Daily, about 180 g of glucose is filtered through the glomerulus but only 0.5 g is excreted in the urine (Bakris et al. 2009 ). It is believed that the bulk of filtered glucose is reabsorbed in the early segment of the proximal tubule by low-affinity high-capacity sodium-glucose cotransporter (SGLT2), while the remaining glucose is reabsorbed in the late proximal tubule by high-affinity low-capacity transporter, SGLT1 (Wright et al. 2011) . The crucial role of SGLT2 in reabsorption of glucose in the kidney is evident in patients with familial renal glucosuria. These patients have mutations in the gene encoding SGLT2 and develop severe glucosuria (Lee et al. 2012; Lee 2013; Santer and Calado 2010) with urinary excretion of glucose as high as 160 g per day (Bakris et al. 2009 ). Studies in mouse showed SGLT2 localization on the BBM of the early proximal tubule and revealed its role in reabsorption of 97 % of the filtered glucose (Sabolic et al. 2012; Vallon et al. 2011) . We hypothesized that SGLT2 is expressed in proximal tubule-like cells in the Bowman's capsule. Here, we tested our hypothesis by immunohistochemical analysis on kidneys of male C57BL/6 mice naturally prone to have tubularized Bowman's capsules (Yabuki et al. 1999) .
The lack of commercial resources for well-characterized specific antibodies against SGLTs has been recognized (Wright et al. 2011) . We previously showed that the N-terminus region of mouse SGLT2 contains amino acid sequences that were divergent from other SGLTs (Tabatabai et al. 2003) , and selected the sequence of the first 16 residues as antigenic peptide (Blodgett et al. 2011) . A polyclonal antibody was raised against this peptide in rabbit and was affinity purified with the antigenic peptide. Western blot analysis on cell lysate proteins from COS-7 cells over-expressing mouse SGLT1 or SGLT2 showed that this antibody hybridized only to SGLT2 (Blodgett et al. 2011 ). In the same study, fluorescence immunocytochemistry with SGLT2 antibody showed strong signals only in COS-7 cells that over expressed the protein further indicating that our SGLT2 antibody is specific. In the present study, immunohistochemical analysis with this novel and specific antibody demonstrated for the first time the localization of SGLT2 expression in tubularized Bowman's capsules in kidneys of C57BL/6 mice.
Materials and Methods

Animals
Male C57BL/6 mice were purchased from Charles River Laboratories (Wilmington, MA). Mice had free access to food and water, and were anesthetized with isoflurane. All procedures had been approved by the Institutional Animal Care and Use Committee at the Medical College of Wisconsin (MCW).
Western Blot Analysis on Kidney Proteins
Kidneys were collected from 4 to 6-week old (wk) mice and were used to prepare total kidney lysate proteins as we described before (Kothinti et al. 2012 ), or to prepare BBM proteins by following a polyethylene glycol precipitation method (Basivireddy and Balasubramanian 2003) . Protein concentration was determined with DC Protein Assay (BioRad; Hercules, CA). Western blot analysis was performed with our SGLT2 antibody on kidney homogenate (25 lg) and BBM (2 lg) proteins using chemiluminescence detection assay as described before (Kothinti et al. 2012; Tabatabai et al. 2005) . As control, experiments were performed with peptide-blocked antibody.
Periodic Acid-Schiff (PAS) Staining, Immunohistochemistry, and Confocal Microscopy Left kidneys were collected from 4, 14, and 22 wk mice and bisected sagittally. Tissues were fixed overnight in buffered zinc formalin, dehydrated through graded alcohols, and embedded in paraffin. Prior to staining, embedded tissues were cut into 4 lm sections, placed on Superfrost Plus slides (Thermo Scientific, Rockford, IL), and dried at 45°C. Tissue sections were then deparaffinized with xylene and rehydrated to water.
For Periodic acid-Schiff (PAS) staining, tissue slides were treated with 0.5 % periodic acid, stained with Schiff reagent, and then counterstained with hematoxylin. For immunohistochemistry, antigen retrieval was performed on tissue sections using citrate buffer (pH 6) (Dako, Carpinteria, CA). After blocking the endogenous peroxidase, nonspecific binding to biotin/avidin, and protein, tissue sections were hybridized with our SGLT2 antibody or with nephrin (N-20) antibody from Santa Cruz Biotechnology (Santa Cruz, CA) and then incubated with biotinylated donkey anti-rabbit or rabbit anti-goat IgG secondary antibody, respectively (Jackson ImmunoResearch Laboratories, West Grove, PA and Vector Laboratories, Burlingame, CA). Next, slides were incubated with HRPconjugated streptavidin (Dako), treated with 3,3 0 -diaminobenzidine (DAB) (Dako), and then counterstained with hematoxylin. Control experiments were performed with peptide-blocked antibodies or in the absence of the primary antibodies. Finally, whole slides were scanned with NanoZoomer system.
For co-localization studies, tissue sections were double stained with nephrin and SGLT2 antibodies and were, respectively, detected with Alexa Fluor 647 and Cy3 conjugated secondary antibodies (Life Technologies, Grand Island, NY and Jackson ImmunoResearch). After counterstaining with 4 0 , 6-Diamidino-2-Phenylindole (DAPI), slides were covered with ProLong Gold mounting medium (Life Technologies). Images were captured with AIM 4.2 software controlling Zeiss LSM510 confocal microscope (Jena, Germany) using C-Apochromat 63x/ 1.45 objective. Images were documented in 8 bit, multitrack mode with DAPI, Cy3, and Alexa-647 dyes excited with 405, 561, and 633 nm lasers and recorded through BP-420-480, BP-575-630, and LP-650 nm filters, respectively.
Quantification of SGLT2-Expressing Renal Corpuscles
Slides from immunohistochemistry with SGLT2 antibody on kidney sections from 6 to 7 mice at each 4, 14, and 22 weeks of age were used to quantify the number of glomeruli with or without SGLT2-stained Bowman's capsules, and the percentage of each in total glomeruli per slide was calculated. The mean values ± standard errors are presented. One Way ANOVA was performed with SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA).
Glomerular Injury
Glomerular injury (glomerulosclerosis and/or mesangial expansion) was assessed in PAS-stained kidney sections. A minimum of 20 randomly selected images (409 magnification) were evaluated in each specimen (Solberg Woods et al. 2010) . Glomerular injury was assessed for individual glomeruli on a 0-4 scale: grade 0, no changes; grade 1, lesions involving \25 %; grade 2, lesions affecting 25-50 %; grade 3, lesions affecting 50-75 %; and grade 4, lesions affecting [75 %.
Results
SGLT2 Expression in Kidneys of Young and Adult Mice
We examined the expression of SGLT2 in kidneys of young and adult male C57BL/6 mice using our polyclonal antibody against mouse SGLT2 peptide. First, Western blot analysis was performed with this antibody on total kidney homogenate and renal BBM proteins (Fig. 1a) . The predicted molecular weight (MW) size of mouse SGLT2 is 73 kDa, but SGLTs may run faster than their predicted MWs on the SDS/PAGE gels due to incomplete denaturation of the protein (Wright et al. 2011) . The results show that our SGLT2 antibody strongly hybridized to a band with MW size of *60 kDa in whole kidney homogenate proteins. A single band with similar MW size was observed in BBM proteins, and this signal was abolished when peptide-blocked antibody was used. These results showed that this antibody recognizes SGLT2 from mouse kidney.
Next, immunohistochemical analysis was performed with our SGLT2 antibody on kidney tissues from 4, 14, and 22 wk mice. The slides were then scanned and their digital images were used for analysis. The results showed that while the kidney size increased with age, the strongest SGLT2 signals were mainly localized in the cortex in kidneys of 4, 14 and 22 wk mice (Fig. 1b) . Tissues were not stained in control experiments with peptide-blocked SGLT2 antibody or in the absence of primary antibody (not shown) supporting that SGLT2 signals were specific. These results showed for the first time the localization of SGLT2 in kidneys of young mice. The results from immunohistochemistry with SGLT2 antibody on kidney tissues from 4, 14, and 22 wk mice were used to investigate whether SGLT2 was expressed in the Bowman's capsule, while the presence or absence of the BBM was examined with PAS staining. The results from these experiments identified the localization of SGLT2 expression on the luminal BBM of the proximal tubule-like cells in the Bowman's capsules in kidneys of young and adult C57BL/6 mice (Fig. 2) .
In specific, in the renal corpuscles from 4 wk mice, most Bowman's capsules were lined with normal brush border-less (Fig. 2a) ; however, tall cuboidal cells with BBM were also occasionally observed (not shown). In contrast, the Bowman's capsule in renal corpuscles from 14 and 22 wk mice was either partially or completely lined with proximal tubule-like cells (Fig. 2b, c) , but the fully tubularized Bowman's capsules were most abundant in 22 wk mice. The morphology of the tubular Bowman's capsule cells was indistinguishable from that of the cells in the proximal tubules. In general, the SGLT2 antibody did not hybridize to parietal epithelial cells; however, regardless of age, strong SGLT2 signals were observed on the luminal side of the tubularized regions of the Bowman's capsules. In 4 wk mice, most Bowman's capsules did not express SGLT2 (Fig. 2d) and SGLT2 stain was only occasionally observed (Fig. 2e) . Unlike in 4 wk mice, partially or fully SGLT2-expressing Bowman's capsules were abundant in kidneys of 14 and 22 wk mice (Fig. 2f-i) , but the prevalence of glomeruli completely encapsulated by SGLT2-expressing layer was the highest in 22 wk mice (Fig. 2i) .
The proximal tubule is connected to the renal corpuscle at the urinary pole of the Bowman's capsule (Nielsen et al. 2012) . Consistently, our results showed proximal tubule cells at the urinary pole of the Bowman's capsules in kidneys of 4 (Fig. 2j), 14 (Fig. 2l) , and 22 wk (Fig. 2n) mice. SGLT2 expression was localized on the apical side of the proximal tubule cells at the glomerulotubular junction as well as in the rest of the early proximal tubule in 4 (Fig. 2k), 14 (Fig. 2m) , and 22 wk (Fig. 2o) mice kidneys. In Bowman's capsules from 4 wk mice, the proximal tubule-like cells were mainly localized adjacent to the glomerulotubular junction (Fig. 2j ), but these cells had expanded toward (Fig. 2l) or had reached (Fig. 2n ) the vascular pole in Bowman's capsules from 14 to 22 wk mice. This directional transition in the Bowman's capsule cell layer morphology paralleled with the appearance of SGLT2 expression near the urinary pole in 4 wk mice (Fig. 2k ) and the expansion of its expression on both sides (Fig. 2m) toward the vascular pole (Fig. 2o ) in 14 and 22 wk mice. In all three age groups, the proximal tubule-like cell layer and the SGLT2 signals in Bowman's capsules were both continuous with that of the epithelial cells in the proximal tubules.
Glomerulus Analysis
We investigated SGLT2 expression in the visceral epithelial cells (podocytes) in kidneys of 4, 14, and 22 wk mice using nephrin as a podocyte marker (Nielsen et al. 2012) . Immunohistochemical analysis with SGLT2 and nephrin antibodies on serially sectioned tissues showed that while nephrin antibody stained all glomeruli, SGLT2 antibody only occasionally stained the Bowman's capsules in the adjacent tissue sections from kidneys of 4 wk mice (Fig. 3a) . There were substantially more glomeruli with than without SGLT2-expressing Bowman's capsules in 14 wk mice, while almost all glomeruli had SGLT2-stained Bowman's capsules in tissues from 22 wk mice. Immunofluorescence analysis on tissues double stained with SGLT2 and nephrin antibodies showed that SGLT2-expressing tubular cells developed in the Bowman's capsule without significant changes in nephrin expression in the glomerulus (Fig. 3b) . Despite strong SGLT2 and nephrin signals, co-localization was not observed in tissues of 4, 14, or 22 wk mice. Glomeruli with SGLT2-expressing capsules constituted 20 ± 5 % of total glomeruli in 4 wk mice but they significantly increased to 70 ± 1 and 87 ± 2 % in 14 and 22 wk mice, respectively (Fig. 3c) . Assessment of glomerular injury in these tissues showed no signs of glomerular sclerosis or mesangial expansion. Fig. 3 Glomerulus analysis. a Representative images from immunohistochemical analysis with nephrin and SGLT2 antibodies on serially sectioned kidney tissues from 4, 14, and 22 wk mice are shown; 910 magnification. Nephrin is expressed in all glomeruli. SGLT2-expressing Bowman's capsules are more abundant in tissues from adult than young mice. G glomerulus. b Representative confocal images from kidney tissue sections from 4, 14, and 22 wk mice double stained with SGLT2 and nephrin antibodies and counterstained with DAPI are shown; 963 magnification. In the renal corpuscles, nephrin signals (green) are in the glomeruli, while SGLT2 signals (red) are on the luminal side of the tubularized Bowman's capsule layer. SGLT2 and nephrin signals do not co-localize. Asterisk, urinary pole. c The average numbers of the total glomeruli in kidney sections from 4, 14, and 22 wk mice were similar and were counted to be 186, 171, and 161 per slide, respectively. The percentage of glomeruli with SGLT2-expressing Bowman's capsules significantly increased with age. *P \ 0.001 between SGLT2-positive and -negative glomeruli at each age; **P \ 0.001 between SGLT2-positive glomeruli at different ages. Results are from 6-7 mice per age group One study showed that the proximal tubule enzymes, alkaline phosphatase and c-glutamyl transpeptidase, were also expressed on the BBM of proximal tubule-like cells in the Bowman's capsules of mouse and rat kidneys (Briere et al. 1983) . And, another study demonstrated protein transport capacity in tubular Bowman's capsule cells by showing the accumulation of horseradish peroxidase, a 40 kDa protein, in these cells 1 h after its injection into mouse (Dietert 1967) . SGLT2 mediates sodium-dependent reabsorption of glucose in the early proximal tubule and, here, we investigated its expression in tubularized Bowman's capsule. It is well established that tubularized Bowman's capsules are present in the kidneys of adult male C57BL/6 mice (Yabuki et al. 1999) . In the present study, tubular metaplasia in Bowman's capsule was found in kidneys of young and adult mice (Fig. 2) . The cuboidal cells with PAS-stained apical brush border member that were found in Bowman's capsules were indistinguishable from the proximal tubule epithelia (Fig. 2j, l, n) . SGLT2 was expressed normally in renal cortex and was localized on the apical side of the early proximal tubules in kidneys of young and adult mice (Figs. 1b; 2k, m, o) . Regardless of age, SGLT2 was also expressed on the luminal BBM of the Bowman's capsule proximal tubule-like cells (Fig. 2e-i) . SGLT2-expressing tubular cells first appeared near the glomerulotubular junction in Bowman's capsules of young mice (Fig. 2k) and then expanded on both sides from the urinary pole toward the vascular pole in older mice (Fig. 2m, o) , but remained continuous with the proximal tubule epithelium.
SGLT2 signal was neither present in parietal epithelial cells (Fig. 2d) nor co-localized with nephrin signal in podocytes (Fig. 3b) suggesting that the renal corpuscle epithelial cells do not express SGLT2. The proportion of glomeruli with SGLT2-expressing Bowman's capsules increased from 20 % in 4 wk mice to almost 90 % in 22 wk mice (Fig. 3a, c ) without significant changes in expression of nephrin (Fig. 3b) or any signs of glomerular injury. These results are consistent with tubular metaplasia in human Bowman's capsule without other significant abnormalities (Finckh and Joske 1954; Ward 1970) .
A new class of antidiabetes drugs is designed to reduce blood glucose by blocking the SGLT2-mediated reabsorption of glucose in the kidney (Bays 2013) . However, the location of SGLT2 expression in the proximal tubule, relative to SGLT1, may play a role in the observed suboptimal effects of SGLT2 inhibitor drugs. It is commonly accepted that SGLT2 mediates the reabsorption of [80 % of filtered glucose; however, treatment of diabetic patients with SGLT2 inhibitors causes only 30-50 % increase in urinary excretion of glucose (Abdul-Ghani et al. 2013) . The reason may be that the inhibition of glucose reabsorption in the early proximal tubule increases glucose concentration in the late proximal tubule lumen, which may in turn enhance SGLT1-mediated glucose reabsorption (Abdul-Ghani et al. 2013; Rieg et al. 2013) , therefore, reducing the effects of SGLT2 inhibition.
Localization of SGLT2 has also been proposed to play role in regulation of glomerular filtration rate (GFR) in diabetes (Gilbert 2013; Vallon 2011) . It was shown that glomerular hyperfiltration developed in streptozotocininduced diabetic wild-type mice but the diabetic SGLT2 knockout mice were protected . It was proposed that this may be due to SGLT2-mediated sodium reabsorption in the early proximal tubule and its downstream effects on sodium concentration in the distal tubule lumen and tubulo-glomerular feedback (Vallon 2011; Vallon et al. 2013) .
In summary, this study demonstrates for the first time SGLT2 localization in tubularized Bowman's capsules in kidneys of C57BL/6 mice. Our results suggest that tubular metaplasia in Bowman's capsule may lead to reabsorption of filtered glucose and sodium in the renal corpuscle, which in turn can affect their concentrations in the proximal and distal tubules lumen. These changes may ultimately alter the blood glucose and the GFR.
